Devraj Srinivasan

Department Of Otolaryngology And Head And Neck Surgery, Lauriston Place, 
Edinburgh, SCT, GB 
Department Of Otolaryngology And Head And Neck Surgery, Lauriston Place, 
Edinburgh, SCT, GB 
OverviewLocationsClinical Research

Overview

Devraj Srinivasan practices in Edinburgh, United Kingdom. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Opsoclonus-Myoclonus Syndrome, Small Cell Lung Cancer (SCLC), and Nasopharyngeal Carcinoma.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Department Of Otolaryngology And Head And Neck Surgery, Lauriston Place, Edinburgh, SCT EH39HX, United Kingdom
Other Locations
London, ENG, United Kingdom
NHS Lothian
United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer
Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 29, 2024
Intervention Type: Drug, Procedure
Study Drugs: Cisplatin, Durvalumab
Study Phase: Phase 3
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

12 Total Publications

Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment.
Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: August 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Srinivasan's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile